심장 폐쇄 디바이스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Heart Closure Devices Market size is expected to reach USD 19.90 Billion in 2034 from USD 5.12 Billion (2025) growing at a CAGR of 16.29% during 2026-2034.

The Global Heart Closure Devices Market is growing steadily as cardiovascular disorders remain a leading cause of mortality worldwide. Devices such as atrial septal defect (ASD) and patent foramen ovale (PFO) closure systems are gaining traction due to minimally invasive procedures and improved patient outcomes. Increasing awareness and early diagnosis of structural heart defects are further boosting market adoption.

Key growth drivers include technological advancements in device design, rising geriatric populations, and expanding access to advanced cardiac care. Minimally invasive catheter-based procedures reduce hospital stays and recovery times, encouraging both patients and healthcare providers to opt for closure devices. Favorable reimbursement policies in developed economies also support market penetration.

Future prospects appear strong with continuous product innovation and expanding clinical research. Emerging markets are expected to offer lucrative growth opportunities due to improving healthcare infrastructure. As interventional cardiology evolves and patient preference shifts toward less invasive treatments, the heart closure devices market will maintain steady upward momentum.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Atrial Septal Defect (ASD) Closure Devices
• Ventricular Septal Defect (VSD) Closure Devices
• Patent Foramen Ovale (PFO) Closure Devices
• Left Atrial Appendage (LAA) Closure Devices
• Other Products

By Material

• Nitinol-Based Devices
• Stainless Steel Devices
• Other Materials

By Mode of Delivery

• Transcatheter Delivery
• Surgical Delivery

By End Use

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Cardiac Catheterization Laboratories
• Other End Users

COMPANIES PROFILED

• Abbott Laboratories, AtriCure, Biosense Webster, Boston Scientific Corporation, Cardia, Heartstitch, Lepu Medical Technology Beijing Co Ltd, LifeTech Scientific Corporation, Medtronic, Occlutech, SentreHEART, Starway Medical Technology, W L Gore Associates
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEART CLOSURE DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Atrial Septal Defect (ASD) Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Ventricular Septal Defect (VSD) Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Patent Foramen Ovale (PFO) Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Left Atrial Appendage (LAA) Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEART CLOSURE DEVICES MARKET: BY MATERIAL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Material
• 5.2. Nitinol-Based Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Stainless Steel Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Other Materials Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEART CLOSURE DEVICES MARKET: BY MODE OF DELIVERY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Mode Of Delivery
• 6.2. Transcatheter Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Surgical Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEART CLOSURE DEVICES MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers (ASCs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Cardiac Catheterization Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HEART CLOSURE DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Material
  • 8.2.3 By Mode Of Delivery
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Material
  • 8.3.3 By Mode Of Delivery
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Material
  • 8.4.3 By Mode Of Delivery
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Material
  • 8.5.3 By Mode Of Delivery
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Material
  • 8.6.3 By Mode Of Delivery
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HEART CLOSURE DEVICES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Abbott Laboratories
  • 10.2.2 AtriCure
  • 10.2.3 Biosense Webster
  • 10.2.4 Boston Scientific Corporation
  • 10.2.5 Cardia
  • 10.2.6 Heartstitch
  • 10.2.7 Lepu Medical Technology (Beijing) Co. Ltd
  • 10.2.8 LifeTech Scientific Corporation
  • 10.2.9 Medtronic
  • 10.2.10 Occlutech
  • 10.2.11 SentreHEART
  • 10.2.12 Starway Medical Technology
  • 10.2.13 W. L. Gore & Associates